http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
위암의 간문맥 전이로 발생한 악성 폐쇄성 황달에 대한 외부 방사선치료 효과
양광모(Kwang Mo Yang),김준희(Joon Hee Kim),김철수(Chul Soo Kim),시현숙(Hyun Suk Suh),김예희(Re Hwe Kim) 대한방사선종양학회 1995 Radiation Oncology Journal Vol.13 No.4
목적 : 위암의 간문맥 임파절 재발로 발생한 악성 폐쇄성 황달치료에 있어서 외부 방사선치료의 효과를 평가해 보고 치료의 결과에 영향을 미칠 수 있는 요인을 알아보고자 하였다. 방법 : 1984년부터 1993년까지 위암의 간문맥 전이로 악성 폐쇄성 황달이 발생한 32명중 3000cGy이상의 방사선량이 조사된 23명을 대상으로 하였다. 치료 결과에 영향을 미칠 수 있는 요인을 알아보기 위하여 방사선량, 황달발생 당시의 질병의 진전정도 및 황달을 일으키는 종괴의 위치, 방사선치료 전 총 bilirubin치, 다른 치료와의 병합여부, 원발병소의 수술정도, 재발전 병기를 분석하였다. 외부 방사선치료는 4백만 전자볼트 선형가속기를 이용하여 주 5회, 1회 180-300cGy를 간문맥을 포함하는 부위에 3000cGy-5480cGy(중앙값 3770cGy, TDF 49-86 3420cGy-5580cGy 중앙값 TDF 65, 4140cGy/23fx)가 조사되었다. TDF 65(4140cGy/23fx) 이상과 미만을 받은 환자는 각각 13, 10명이었다. 결과 : 전체 환자 32명중 완전관해 13명, 부분관해 5명, 무반응 5명이었다. 전체 환자의 종양 생존 기간은 5개월이나 완전관해의 경우는 11개월이고 부분관해와 무반응의 경우 각각 3개월이었다. 완전관해를 보인 13명중 6명이 1년 이상 생존하였다. 완전관해의 경우와 부분관해, 무반응과의 생존 기간의 비교에서 의미있는 차이를 보였다(p Purpose : Since 1983, authors have conducted a study to evaluate the effect of external radiation therapy and to determine affected factors in management of the patients with malignant obstructive jaundice due to porta hepatis metastasis from stomach cancer. Materials and Methods : Thirty two patients with malignant obstructive jaundice due to porta hepatis metastasis from gastric cancer were presented. We have analysed 23 patients who were treated with external radiation therapy of more than 3000cGy. The radiation dose, disease extent at development of jaundice, total bilirubin levels before radiation therapy. initial stage of gastric cancer were analyzed to determine affected factors in radiation therapy. External radiation therapy was delivered with a daily dose of 180-300cGy. 5 times a week fractionation using 4 MeV linear accelerator. The radiation field included the porta hepatis with tumor mass received more than 3000cGy. total irradiation dose was ranged from 3000cGy to 5480cGy. median 3770cGy. Among 23 patients, 13 patients were delivered more than equivalent dose of TDF 65(4140cGy/23fx). Results : Among 23 patients, complete, partial and no response were observed in 13, 5, 5 patients, respectively. The median survival for all patients was 5 months. The significant prolongation of median survival was observed in complete responder(11 months) as compared to partial and no responders(5 months, 5 months, respectively). Out of 13 patients with complete response, 6 patients lived more than a year. Among 13 patients receiving more than 4140cGy equivalent dose, complete, partial and no response were observed in 10.2 and 1 patients, respectively. The median survival for all these patients was 9.5 months. The median survival for complete responders(10/13) was 11.5 months. Among 10 patients receiving less than 4140cGy equivalent dose, complete, partial and no response were observed in 3, 3, 4 patients. respectively. The median survival for all these patients was 4.3 months. therefore, the radiation dose affected the results of treatment. For the complete response with prolongation of survival duration, at least 4140cGy equivalant dose should be delivered to porta hepatis. In valuation of the disease extent, 7 patients of 13 complete responders showed localized disease in porta hepatis or peripancreatic area, but all patients with partial and no response showed wide extensive disease or persistant disease of primary gastric cancer. Therefore, the patients with the localized disease were the higher probability of complete response and long term survival. This study suggested that the radiation dose and the disease extent at development of jaundice affected in radiation therapy for malignant obstructive jaundice. There were no serious complications related to external radiation therapy. Conclusion : External radiation therapy only could achieve the palliative effect in the patients with malignant obstrctive jaundice due to porta hepatis metastasis from stomach cancer. This study suggested that the prolongation of survival duration could be acheived in complete responders and radiation dose. extent of disease affected the results of treatment of malignant obstructive jaundice
진행성 비소세포 폐암에 대한 5 - Fluorouracil , Vinblastine 과 Cisplatin ( FVP ) 의 복합화학요법
최홍집(Hong Jib Choi),김성록(Sung Rok Kim),양성현(Sung Hyun Yang),최수전(Soo Jeon Choi),김철수(Chul Soo Kim),김예희(Re Hwe Kim) 대한내과학회 1997 대한내과학회지 Vol.53 No.1
The 5 year survival rate after surgical resection for stage III non-small cell lung cancer(NSCLC) remains short, only 10-19%. Radiotherapy seems to show some benefit for local control, but it does not reflect to prolongation of survival, as distant metastasis prevails. Vinblastine is one of the most active agent against NSCLC. 5-Fluorouracil(5-FU) and cisplatin are synergistic in anti-cancer activity in adenocarcinoma of gastrointestinal tract and squamous cell cancer of head and neck. We initiated a phase II trial for advanced NSCLC to determine the effect of FVP regimen in response rate, survival and toxicities. The therapy consisted of 5-FU 500mg/m2/12 hours continious IV infusion for 36 hours from day 1, vinblastine 3mg/m2 IV bolus day 1 and 2, cisplatin 75mg/m2 IV infusion over 2 hours day 1 and it was repeated every 3 weeks. Among the 45 patients entered into this study, 40 patients were evaluable for response. The objective response rate was 50%(CR;1/40, 2.5% PRi19/40, 47.5%). The median survival of all the patients was 42.9 weeks(8.4+ - 140.6 weeks); the responding patients survived longer than the non-responders(mediansurvival; 54.4 weeks vs 29.7 weeks, p<0.05). The toxicities of this regimen were acceptable but 1 patient died of pneumonia associated with granulocytopenia. We concluded that the FVP regimen is effective in the treatment of advanced non-small cell lung cancer and a prospective randomized trial and long- term follow up is warranted.
류마티스 관절염 양상으로 발현한 다발성 골수종에 의한 아밀로이드 관절병증
한성훈 ( Seong Hoon Han ),양대원 ( Dae Won Yang ),김동욱 ( Dong Yook Kim ),김준희 ( Joon Hee Kim ),신보문 ( Bo Moon Shin ),이윤우 ( Yun Woo Lee ),김예희 ( Re Hwe Kim ) 대한류마티스학회 1998 대한류마티스학회지 Vol.5 No.2
Amyloid arthropathies in patients with multiple myeloma have been reported rarely in the world. In Korea, only one case of amyloid arthropathy with multiple myeloma was reported, but there had been no report of multiple myeloma which was initially manifested as a polyarthritis simulating rheumatoid arthritis. We report a case of multiple myeloma with amyloid arthropathy. The patient was 62 years old man, who had had progressive bilateral shoulder pain for one year. Since 6 months prior to admission, progressive painful swelling developed in bilateral hips, shoulders, wrists and hands. Simple X-rays and MRI of shoulders and hips showed huge osteolytic mass, and the amyloid was found in the biopsy of the mass in hip. The diagnosis of multiple myeloma was made after bone marrow biopsy and biochemical studies, but X-rays of skeletal survey didn`t show typical osteolytic lesions of multiple myeloma at the time of diagnosis.
정성광(Sung Kwang Chung),송영수(Young Soo Song),김준희(Joon Hee Kim),전영빈(Young Bin Jeon),이윤우(Yun Woo Lee),김철수(Chul Soo Kim),김예희(Re Hwe Kim),강윤경(Yun Kyung Kang),이혜경(Hye Kyung Lee) 대한내과학회 1996 대한내과학회지 Vol.51 No.3
Superficial migratory thrombophlebitis represents multiple, tender, often cord like nodules uaually on the legs but occasionally on the arms. It can be associated with internal malignancy or other systemic disease, such as varicose veins, thromboangitis obliterans, but also occurs idiopathically. Recently we experienced a patients with superficial migratory thrombophlebitis, chronic disseminated intravascular coagulation associated with adenocarcinoma of the stomach. A 35-year-old man was admitted to our hospital because of the pain and swelling of left lower leg for one month. An erythematous tender swelling along the superficial vein in above area was found and the skin biopsy disclosed perivascular lymphocytic infiltration and interstitial edema of subcutaneous tissue. Abdominal CT showed a localized ulcerating wall thickening involving the greater curvature of anterior wall of lower body of stomach, which was confirmed as adenocarcinoma with gastrofiberscopic biopsy. The blood level of FDP was increased and fibrinogen was decreased. The patient surgery was discharged against advise of surgery.